「pr」の検索結果
229件：66～70件目を表示
-
Ltd. Launch of Distribution of RET-700 Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter “Senju”) hereby announces the launch of distribution of R...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240726_0.pdf -
Ltd. Launch of Distribution of RET-700 Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter “Senju”) hereby announces the launch of distribution of R...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240726.pdf -
General Announcement: September 3, 2024 Senju Pharmaceutical Co., Ltd. Acquisition of Marketing Approval for “ Mytear LUMIFY” Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr....
https://www.senju.co.jp/system/files/content_news/2024-08/ENG_20240903_0.pdf -
General Announcement: September 3, 2024 Senju Pharmaceutical Co., Ltd. Acquisition of Marketing Approval for “ Mytear LUMIFY” Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr....
https://www.senju.co.jp/system/files/content_news/2024-08/ENG_20240903.pdf -
bution of Software for Dry-eye Analysis Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter “Senju”) hereby announces the launch of distribution of s...
https://www.senju.co.jp/system/files/content_news/2024-09/ENG_20240906.pdf